# Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia

> **NCT02869971** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 90 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** Embosphere® (Prostatic Arteries Embolization)
- **DRUG:** Drug therapy

## Key facts

- **NCT ID:** NCT02869971
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-12-03
- **Final completion:** 2022-03-25
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02869971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02869971, "Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02869971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*